Gevo, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US3743964062
USD
2.37
0.21 (9.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Gevo, Inc. stock-summary
stock-summary
Gevo, Inc.
Specialty Chemicals
Gevo Inc. is engaged in commercializing jet fuel, gasoline and diesel fuel. The Company’s fermentation yeast biocatalyst produces isobutanol through fermentation of renewable plant biomass. It operates through two segments: Gevo, Inc. (Gevo) segment and Gevo Development/Agri-Energy segment. Gevo segment is responsible for research and development activities related to the production of isobutanol, including the development of the Company's biocatalysts, the production and sale of renewable jet and other fuels, the Retrofit process and the generation of chemicals and biofuels. The Gevo Development/Agri-Energy segment is responsible for the operation of the Luverne Facility and the production of ethanol, isobutanol and related products. Its products include renewable gasoline, renewable biodiesel, isooctane, sustainable aviation fuel (SAF), isobutylene, ethanol and animal feed.
Company Coordinates stock-summary
Company Details
Building C, 345 Inverness Dr S Ste 310 , ENGLEWOOD CO : 80112-5892
stock-summary
Tel: 1 303 85883581 415 2337094
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 35 Schemes (19.33%)

Foreign Institutions

Held by 56 Foreign Institutions (8.27%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Ruth Dreessen
Independent Chairman of the Board
Dr. Patrick Gruber
Chief Executive Officer, Director
Mr. William Baum
Independent Director
Mr. Andrew Marsh
Independent Director
Mr. Gary Mize
Independent Director
Mr. Johannes Roth
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
43 Million
(Quarterly Results - Jun 2025)
Net Profit:
3 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 397 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

-10.22%

stock-summary
Price to Book

0.84